Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity reports news about its digital platform for U.S. medical professionals, including tools for clinical collaboration, medical news and research, career and on-call management, documentation workflows, and virtual patient visits. Company updates commonly cover quarterly financial results, platform engagement, workflow products, and AI-powered clinical reference and search capabilities.
Recurring developments also include Doximity Dialer telehealth recognition, physician research on AI adoption, and the integration of Pathway Medical into Doximity's clinical reference offerings. The company's news flow links product expansion with its verified medical-professional network and its role in digital workflow tools built for physicians.
Summary not available.
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, will announce its financial results for the fiscal fourth quarter ending March 31, 2023, on May 16, 2023, after market close.
The company will hold a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results, which can be accessed via the Company’s Investor Relations page.
Doximity's platform enables collaboration among over 80% of U.S. physicians, providing essential digital tools for improved productivity and patient care.
Doximity, Inc. (NYSE: DOCS) released its 2023 Physician Compensation Report, revealing a 2.4% decline in average pay for U.S. physicians in 2022. Over 190,000 doctors provided self-reported compensation data. The report also highlights a significant 26% gender pay gap, with men earning nearly $110,000 more than women. A looming 2% Medicare payment cut adds to the economic challenges faced by physicians. Despite stagnant pay, there is high demand for primary care specialties. Doximity aims to increase transparency regarding compensation and pressures within the medical profession.
Doximity, Inc. (NYSE: DOCS) has announced an Investor Day scheduled for June 6, 2023, at the New York Stock Exchange in New York City. The event will run from 10:30 a.m. to 1:30 p.m. Eastern Time. A live webcast will be available on the Company’s Investor Relations page, with a replay accessible afterwards. Founded in 2010, Doximity is a leading digital platform for U.S. medical professionals, serving over 80% of U.S. physicians across various specialties. The company aims to enhance productivity in healthcare through innovative digital tools.
Doximity, Inc. (NYSE: DOCS) announced that CFO Anna Bryson will present at the Raymond James 44th Annual Institutional Investors Conference on Wednesday, March 8, 2023, at 9:15 a.m. Eastern Time. Doximity is a leading digital platform for U.S. medical professionals, with a network that includes over 80% of U.S. physicians across all specialties. The platform offers tools for collaboration, access to medical news, career management, and virtual patient visits. Founded in 2010, Doximity aims to enhance doctors' productivity to improve patient care.
Doximity (NYSE: DOCS) announced that its telehealth platform, Doximity Dialer, has been awarded the 2023 ‘Best in KLAS’ for the second consecutive year in the Telehealth - Video Conferencing segment. The platform excelled in areas such as culture, loyalty, operations, product, relationship, and value, showcasing its user-friendly experience. A record 375,000 unique providers utilized Dialer last quarter, enhancing patient care through HIPAA-compliant features like one-click video visits. The KLAS report recognizes top healthcare IT solutions based on extensive evaluations, emphasizing Doximity's significant role in advancing digital healthcare.
Doximity, Inc. (NYSE: DOCS) reported total revenues of $115.3 million for Q3 fiscal 2023, reflecting an 18% increase year-over-year. Operating cash flow reached $48.7 million, up 78%, while free cash flow surged to $47.5 million, marking an 85% growth. However, net income decreased to $33.5 million from $55.6 million, resulting in a net income margin of 29%. For Q4, the company forecasts revenue of $109.6 million to $110.6 million and maintains a positive outlook for FY 2024, projecting revenues over $500 million.
Doximity, Inc. (NYSE:DOCS) announced it will report its fiscal third-quarter financial results for the period ending December 31, 2022 on February 9, 2023, after market close. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results in detail. Doximity is recognized as the leading digital platform connecting over 80% of U.S. physicians across various specialties, offering tools that enhance productivity and patient care.
Doximity, Inc. (NYSE: DOCS) has announced that CFO Anna Bryson will participate in a fireside chat at the Raymond James Technology Investor Conference on December 5, 2022, at 10:20 a.m. Eastern Time. Doximity is a leading digital platform for U.S. medical professionals, with over 80% of U.S. physicians as members. The platform offers various digital tools to enhance productivity, allowing members to collaborate, stay updated on medical news, manage careers, and conduct virtual patient visits. Visit www.doximity.com for more information.
Doximity, Inc. (NYSE: DOCS) reported Q2 2023 total revenues of $102.2 million, a 29% year-over-year increase. Operating cash flow rose to $39.5 million (+106%), with free cash flow reaching $37.7 million (+109%). Net income fell to $26.3 million (margin of 26%) compared to the previous year, while non-GAAP net income was $36.2 million (35% margin). Doximity projects Q3 2023 revenue between $110.7 million and $111.7 million, affirming full-year revenue guidance of $424.0 million to $432.0 million. A $70 million stock repurchase program was also authorized.